Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R M Hay

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|October 14, 2008
Osteopenic fractures in pregnancy: is low molecular weight heparin (LMWH) implicated?L M Byrd, C R Shiach, C R M Hay, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 15, 2017
The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors OrganisationC R M Hay, H Xiang, M Scott, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experienceD M DiMichele, P O Gorman, C K Kasper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 25, 2016
The impact of sport on health status, psychological well-being and physical performance of adults with haemophiliaS von Mackensen, C Harrington, E Tuddenham, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 16, 2009
The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of EnglandM S Sutherland, S Keeney, P H B Bolton-Maggs, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 17, 2017
Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficencyG N Pike, A M Cumming, J Thachil, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 19, 2016
Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiencyG N Pike, A M Cumming, J Thachil, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgeryC R M Hay, A Hellmann, A Dmoszynska, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2015
Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance studyV Rodriguez, M E Mancuso, D Warad, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2018
The immunogenicity of ReFacto AF (moroctocog alfa AF-CC) in previously untreated patients with haemophilia A in the United KingdomM C Mathias, P W Collins, B P Palmer, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|October 14, 2008
Osteopenic fractures in pregnancy: is low molecular weight heparin (LMWH) implicated?L M Byrd, C R Shiach, C R M Hay, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 15, 2017
The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors OrganisationC R M Hay, H Xiang, M Scott, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experienceD M DiMichele, P O Gorman, C K Kasper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 25, 2016
The impact of sport on health status, psychological well-being and physical performance of adults with haemophiliaS von Mackensen, C Harrington, E Tuddenham, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 16, 2009
The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of EnglandM S Sutherland, S Keeney, P H B Bolton-Maggs, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 17, 2017
Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficencyG N Pike, A M Cumming, J Thachil, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 19, 2016
Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiencyG N Pike, A M Cumming, J Thachil, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgeryC R M Hay, A Hellmann, A Dmoszynska, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2015
Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance studyV Rodriguez, M E Mancuso, D Warad, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2018
The immunogenicity of ReFacto AF (moroctocog alfa AF-CC) in previously untreated patients with haemophilia A in the United KingdomM C Mathias, P W Collins, B P Palmer, et al.
Pageof 4